Greece’s economy to shrink by estimated 8.2% this year

Eufemia Didonato

ATHENS, Greece (AP) — Greece’s economy will contract by an estimated 8.2% this year due to the effects of the coronavirus pandemic before picking up next year, the government said Monday as it submitted its 2021 draft budget to parliament. The 2021 budget was “drawn up in an environment of […]

ATHENS, Greece (AP) — Greece’s economy will contract by an estimated 8.2% this year due to the effects of the coronavirus pandemic before picking up next year, the government said Monday as it submitted its 2021 draft budget to parliament.

The 2021 budget was “drawn up in an environment of unprecedented uncertainty, due to the indefinite expiration date of the unprecedented coronavirus pandemic,” government spokesman Stelios Petsas said.

Greece emerged nearly two years ago from eight years of international bailout programs, during which it made deep spending cuts and tax increases to qualify for rescue loans. Its financial crisis sent unemployment skyrocketing and wiped out a quarter of the economy.


The country’s public debt is projected to reach 337 billion euros this year, or 197.4% of gross domestic product. That would fall slightly to 342 billion euros, or 184.7% of GDP, in 2021, according to the draft budget. Unemployment is forecast to rise to 18.6% this year, compared with 17.3% last year, before dipping to 16.5% next year.

Petsas said the recession forecast for 2020 is less severe than the 8.7% contraction estimated for the eurozone as a whole. The economy is expected to bounce back 7.5% next year, so that “Greek people’s income will remain almost unchanged” during the two-year period, the budget said.

The primary budget balance – that is, the government’s budget without taking into account the cost of servicing debt – will tumble to a deficit of 6.2% this year, and remain in a deficit of about 1% next year.

Source Article

Next Post

2 Timeless Pharma Stocks to Buy After the Next Market Crash

In the event of another market crash this year, healthcare investors will benefit in the long term from having bought shares of rock-solid pharmaceutical companies while they’re less expensive. In my view, pharmaceutical companies demonstrate their value by maintaining profitable operations over time, developing strong domain expertise within the markets […]